Member of Farmavita.net is offering dossier in European CTD format for Spironolactone; 25/50/100 mg, tablets.
Dossier is registered in The Netherlands.
License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Spironolactone is classified as a cardiovascular system medicine, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|Pharma licensing||Out-licensing (offer)|